Cardiome Pharma (CRME) Misses Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cardiome Reports First Quarter 2017 Financial Results
May 15, 2017 4:00 PM EDTNASDAQ: CRMEÂ Â TSX: COM
Cardiome to conduct conference call and webcast today, May 15, 2017 at 4:30 p.m. Eastern (1:30 p.m. Pacific)
VANCOUVER, May 15, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for its first quarter ended March 31, 2017. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP).Â
Q1 2017 Highlights:
Cardiome received a Notice... More